Pharmaceutical Manufacturing in China

  • January 2014
  • -
  • Ibisworld
  • -
  • 37 pages

Pharmaceutical Manufacturing in China

The Pharmaceutical Manufacturing Industry in China is primarily engaged in the manufacture of chemical medicinal and pharmaceutical products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. These products are then sold via pharmacies or distributed via hospitals. Biological and veterinary medicine products are not included in this industry.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Table Of Contents

Pharmaceutical Manufacturing in China

TABLE OF CONTENTS

ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources

INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

PRODUCTS and MARKETS
Supply Chain
Products and Services
Demand Determinants
Major Markets
International Trade
Business Locations

COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization

MAJOR COMPANIES

OPERATING CONDITIONS
Capital Intensity
Technology and Systems
Revenue Volatility
Regulation and Policy
Industry Assistance

KEY STATISTICS
Industry Data
Annual Change
Key Ratios

JARGON

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the ...

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

  • $ 7 995
  • Industry report
  • November 2014
  • by Global Data

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023 Summary There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.